Menu Menu

News

Topics
Featured
COVID-19 Research Pipeline

216,681

Registered/ Published

4,604

Registered

793

Published

8,000

Registered
As at 23 June 2023
FILTERED BY > Venous thromboembolism (VTE) prophylaxis Clear filter

Weekly Communique #33

26 November, 2020
WEEK IN REVIEW Updates to the living guideline Three new recommendations have been published this week covering: Bamlanivimab Fluvoxamine Intravenous immunoglobulin VTE prophylaxis for children and adolescents Further details are below. Taskforce reviewing changes to WHO guidance on remdesivir for adults Last week, the World Health Organisation (WHO) modified its recommendation on remdesivir to a conditional recommendation against its use for all hospitalised patients regardless of disease...
Communique

Weekly Communique #23

17 September, 2020
WEEK IN REVIEW New recommendations on VTE prophylaxis for pregnant and postpartum women The Pregnancy and Perinatal Care Panel together with the Expert Advisory Group have developed four new consensus...
Communique

Weekly Communique #17

6 August, 2020
WEEK IN REVIEW 'Do not use': The Taskforce has strengthened its recommendation against the use of hydroxychloroquine as a treatment for COVID-19 This week the Taskforce upgraded the strength...
Communique

Weekly Communique #7

28 May, 2020
WEEK IN REVIEW The Taskforce has issued a consensus recommendation to consider increased-dose venous thromboembolism (VTE) prophylaxis for adults with severe to critical COVID-19. This recommendation was developed with input from thrombosis specialists on the Taskforce's...
Communique

Weekly Communique #4

8 May, 2020
WEEK IN REVIEW We welcomed the following new members to the Taskforce: Australian College of Midwives Key new topics of discussion across the panels this week included: Publication...
Communique